Intraocular Pressure Clinical Trial
Official title:
Effects of Elevated Intraocular Pressure on the Lamina Cribrosa
The purpose of this study is to improve understanding of the pathophysiologic process that leads to the development of glaucamotous damage. The mechanism by which vision loss in glaucoma occurs is still unknown, but it is clear that increased intraocular pressure (IOP) is a major risk factor. It is also thought that the LC is a site of primary damage during pathogenesis of the disease. This prospective study with determine the in-vivo mechanical response to IOP modulation at the level of the ONH and LC.
Status | Recruiting |
Enrollment | 150 |
Est. completion date | May 8, 2024 |
Est. primary completion date | May 8, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility | Inclusion Criteria: Healthy volunteers - No family history (first degree relative) of glaucoma. - No history of IOP >22 mmHg. - Normal appearing optic discs and RNFL on dilated fundus examination. - Normal Swedish interactive thresholding algorithm (SITA) standard perimetry tests as defined by glaucoma hemifield test (GHT) within normal limits. Glaucoma suspects - Normal visual field as defined above. - Either IOP between 25 to 30 mmHg with central corneal thickness < 550µm, or a difference = 0.2 in cup to disc ratio between eyes. Glaucoma - Glaucomatous ONH abnormality: rim thinning, notching, undermining (excavation) or diffuse or localized RNFL defects that are characteristic of glaucoma. - Two consecutive abnormal SITA standard perimetry tests with GHT outside normal limits. Exclusion Criteria: - Media opacity (e.g. lens, vitreous, cornea). - Strabismus, nystagmus or a condition that would prevent fixation. - Diabetes with evidence of retinopathy. - Previous intraocular surgery or ocular trauma (with the exception of laser procedures and subjects that have undergone uneventful cataract surgery more than 6 months from enrollment date). - Neurological and non-glaucomatous causes for visual field damage. - Any intraocular non-glaucomatous ocular disorders. |
Country | Name | City | State |
---|---|---|---|
United States | NYU Langone Health | New York | New York |
Lead Sponsor | Collaborator |
---|---|
NYU Langone Health | National Eye Institute (NEI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Assessment of the deformation of the lamina cribrosa in healthy eye in response to increasing intraocular pressure. | OCT scanning will be obtained at baseline and with increased IOP. The IOP elevation will last no longer than two minutes, during which scans will be acquired by the imaging device. | 10 Minutes | |
Primary | Assessment of the deformation of the lamina cribrosa in glaucoma suspect, in response to increasing intraocular pressure. | OCT scanning will be obtained at baseline and with increased IOP. The IOP elevation will last no longer than two minutes, during which scans will be acquired by the imaging device. | 10 Minutes | |
Primary | Assessment of the deformation of the lamina cribrosa in glaucomatous eyes in response to increasing intraocular pressure. | OCT scanning will be obtained at baseline and with increased IOP. The IOP elevation will last no longer than two minutes, during which scans will be acquired by the imaging device. | 10 Minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT03016234 -
IOP Changes With Different Anesthetic Agents During Laparoscopic Colorectal Surgery
|
N/A | |
Completed |
NCT04863209 -
Effect of Osteopathic Techiniques on Intraocular Pressure
|
N/A | |
Completed |
NCT03139708 -
The Effect of Brimonidine on Intraocular Pressure When Dilating Routine Patients
|
Phase 1 | |
Completed |
NCT02646033 -
Quantitative Rise in Intraocular Pressure in Steep Trendelenburg Position
|
||
Recruiting |
NCT02697825 -
Intraocular Pressure Versus Optic Nerve Sheath Diameter
|
N/A | |
Completed |
NCT02985567 -
An Observational Study of the Use of Chloral Hydrate for Ophthalmic Procedures in Children
|
N/A | |
Withdrawn |
NCT00837226 -
Effects of Weight Loss From Bariatric Surgery on Intraocular Pressure (IOP)
|
N/A | |
Completed |
NCT02136589 -
Effect of NSAID on Travoprost-induced Conjunctival Hyperemia and IOP Reduction in Normal Eyes
|
Phase 4 | |
Completed |
NCT03123614 -
Loteprednol vs. Prednisolone and Fluorometholone
|
Phase 4 | |
Completed |
NCT05763056 -
Effects of Intubation on Intra-ocular Pressure and Optic Nerve Sheath Diameter
|
N/A | |
Completed |
NCT03359200 -
Analysis of the Microbiota in Goldmann Applanation Tonometers at a Reference Service in Goiânia
|
N/A | |
Withdrawn |
NCT02558309 -
Optic Nerve Head Quantification While Reducing Elevated Intracranial Pressure
|
N/A | |
Completed |
NCT02816905 -
Ocular-hypertensive Response to Topical Steroids in Children After Bilateral Strabismus Surgery
|
Phase 4 | |
Completed |
NCT01786954 -
iCare vs Tonopen vs Goldmann Applanation Post-vitrectomy Surgery
|
N/A | |
Completed |
NCT00552019 -
Intraocular Pressure (IOP) Assessed by Dynamic Contour Tonometer (DCT) and Goldman Applanation Tonometry (GAT)
|
N/A | |
Completed |
NCT00428740 -
Long-Term IOP Fluctuation and VF Progression After Triple Procedure
|
N/A | |
Completed |
NCT04360369 -
Comparison of Intraocular Pressure Measurements Between Reichert Tono-Vera Tonometer and Goldmann Tonometry
|
N/A | |
Completed |
NCT04521140 -
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery
|
Phase 4 | |
Completed |
NCT05167773 -
Clinical Study of the Topcon Tonometer TRK-3
|